Presenter(s): Thomas R. Kosten, MD, Waggoner Professor in Psychiatry, Pharmacology, Neuroscience, Baylor College of Medicine; Fang Yang, MD, PhD, Addiction Psychiatry Fellow, Baylor College of Medicine
Target Audience: This activity was developed to meet the needs of psychiatric clinicians (medical doctors, psychiatric nurses).
Webinar description: Fentanyl is the leading cause of opioid overdoses during the last couple of years, and these overdoses are not prevented by methadone, buprenorphine or naltrexone treatment. However, a vaccine against fentanyl has been able to block fentanyl’s analgesic, reinforcing and respiratory depressant effects in animal models. This vaccine is moving toward FDA approval to be tested in humans.
- Identify the extent and greatest geographic concentration of fentanyl overdoses and abuse in the current USA opioid epidemic.
- Define how and why current treatments with naltrexone, methadone and buprenorphine are ineffective for fentanyl abuse.
- Identify the mechanism of action for fentanyl vaccines in preventing overdoses and abuse through the production of anti-fentanyl antibodies.
The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
American Psychiatric Association (APA) designates this live activity for a maximum of 1 (one) AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.